DNA-directed RNA polymerase subunit alpha (RpoA)

The Bacterial DNA-directed RNA polymerase alpha subunit, encoded by the rpoA gene, is a fundamental component of the multi-subunit RNA polymerase (RNAP) core enzyme (alpha2beta-beta'-omega) [7, 12]. It serves as the essential scaffold for the assembly of the RNAP complex, with its dimerization being the first step in the sequential recruitment of the larger catalytic subunits, beta and beta' [4, 13, 20]. Beyond its structural role, the alpha subunit contains a flexible C-terminal domain (alpha-CTD) that facilitates interactions with DNA upstream promoter elements and a wide array of transcription factors, making it a pivotal regulator of gene expression and stress responses [1, 4, 11]. In the context of infectious diseases, the alpha subunit is a critical therapeutic target because it is indispensable for bacterial viability and virulence [2, 8, 16]. While established antibiotics like the rifamycins primarily target the beta subunit of the RNAP complex, the alpha subunit is an emerging target for novel antibiotics, particularly those designed to disrupt protein-protein interactions or enzyme assembly [2, 8]. Mutations in the rpoA gene can lead to altered antibiotic susceptibility and have been implicated in the regulation of virulence factors such as efflux pumps and quorum sensing [9, 10]. Targeting this subunit offers a strategy for broad-spectrum antibacterial activity with potential selectivity over eukaryotic RNA polymerases [8, 16].

Other names

RNA polymerase subunit alphaRNAP subunit alphaTranscriptase subunit alpharpoABacterial RNA polymerase alpha subunit

Inhibition of bacterial RNA synthesis by binding to the RNA polymerase complex, disruption of enzyme assembly, or interference with transcription factor interactions [2, 8, 16].